FORWARD PHARMA A/S

FWP
Delayed Quote. Delayed  - 09/29 03:55:11 pm
3.1USD +1.64%
Valuation
Fiscal Period: December 2020 2021
Capitalization1 47,741,9
Enterprise Value (EV)1 -31,3-28,9
P/E ratio -7,17x-22,0x
Yield --
Capitalization / Revenue --
EV / Revenue --
EV / EBITDA 9,26x-
Price to Book 0,62x0,59x
Nbr of stocks (in thousands) 6 7917 019
Reference price () 7,035,97
Announcement Date 04/14/202104/08/2022
Previous period Next period
1 USD in Million
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2020 2021
Net sales --
EBITDA1 -3,39-
Operating profit (EBIT)1 -3,39-3,87
Operating Margin --
Pre-Tax Profit (EBT)1 -6,45-1,89
Net income1 -6,45-1,89
Net margin --
EPS2 -0,98-0,27
Dividend per Share --
Announcement Date 04/14/202104/08/2022
Previous period Next period
1 USD in Million
2 USD
Finances - Leverage
Fiscal Period: December 2020 2021
Net Debt1 --
Net Cash position1 79,170,8
Leverage (Debt / EBITDA) 23,4x-
Free Cash Flow1 -1,43-3,01
ROE (Net Profit / Equities) -8,26%-2,53%
Shareholders' equity1 78,174,7
ROA (Net Profit / Asset) -2,68%-3,20%
Assets1 24159,0
Book Value Per Share2 11,410,1
Cash Flow per Share2 11,510,1
Capex1 --
Capex / Sales --
Announcement Date 04/14/202104/08/2022
Previous period Next period
1 USD in Million
2 USD
Change in Enterprise Value/EBITDA
EPS & Dividend